ArticleJournal of cancer survivorship : research and practice2025
Using machine learning to identify speech markers of subjective cognitive impairment in breast cancer survivors.
Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCancer-related cognitive impairment (CRCI) refers to cognitive changes described by cancer patients. While subjective cognitive difficulties in survivors are well screened by questionnaires, CRCI remains seldom diagnosed by neuropsychological tests. New objective approaches are needed to detect CRCI. The goal of this study is to find the speech markers that can best detect CRCI.
methodsForty-four women who completed breast cancer treatment and 13 controls were asked to narrate a picture-based story. Speech productions were recorded and analyzed using semi-automatic methods. Fourteen speech features were extracted and incorporated in machine learning models to classify CRCI assessed using the FACT-Cog questionnaire. In addition, all participants underwent psychological assessment to control for confounding factors.
resultsThe combination of speech-to-silence ratio, mean duration of silent pauses, and mean duration of filled pauses best predicted cancer survivors with CRCI (ROC = 0.74, accuracy = 73.7%). Bayesian Generalized Linear Models further showed that silence in participants' speech depended on whether they had CRCI and reported depression assessed using the HADS. Credibility Intervals of regression coefficients showed only a trend for reported depression (95% CI [- 0.36, - 0.00]), while scores were below clinical thresholds for depressive disorders for all groups.
conclusionsLong silent pauses in discourse may be a sign of cancer-related cognitive impairment in survivors of breast cancer. IMPLICATIONS FOR CANCER SURVIVORS: This study demonstrates the benefits of using speech analysis as a fast, ecological, and non-invasive technique for assessing CRCI.
Indexed as
Identifiers
40888831What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.